Company: PCAP
Filing Date: 2025-04-10
Form Type: DRSLTR
Source: 0001213900-25-030771
Chunk: 0

Company: ProCap Acquisition Corp
Filing Date: 2025-04-10
Form: DRSLTR
Chunk 0
---
|                      | Reed Smith LLP |
| 1221 McKinney Street |                |
| Suite 2100           |                |
| Houston, TX 77010    |                |
| +713 469 3800        |                |
| reedsmith.com        |                |

VIA EDGAR

April 10, 2025

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street, NE

Washington, D.C. 20549

Ladies and Gentlemen:

On behalf of ProCap Acquisition
Corp, a Cayman Islands exempted company (the “Company”), we submit the Company’s response to the comment letter
received from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”)
dated March 19, 2025, regarding the Company’s Draft Registration Statement on Form S-1 confidentially submitted to the Commission
on February 20, 2025 (the “DRS”). For the Staff’s convenience, we have repeated below each of the Staff’s
comments in bold and have followed such comment with the Company’s response. Simultaneous with this response letter, we have filed
an amendment to the DRS with the Commission through EDGAR on an amendment to the Draft Registration Statement on Form S-1 (the “Registration Statement”). The Registration Statement reflects the Company’s responses to the comments received by the Staff on February
20, 2025. All page references in the responses set forth below refer to page numbers in the Registration Statement.

| 1. | We note disclosures on page 102 and elsewhere that if you increase                                                                      
 or decrease the size of the offering, you will effect a share capitalization or a share repurchase or redemption or other appropriate   
 mechanism, as applicable with respect to your Class B shares in such amount so that the founder shares will continue to represent 20%   
 of your issued and outstanding ordinary shares upon consummation of the offering. Please discuss these provisions on the cover page and 
 in the discussions of securities that may become issuable to the sponsor in the sections entitled “Sponsor Information” on              
 page 10 and “Our Sponsor” on page 106.                                                                                                  |

Company Response

The Company acknowledges the Staff’s comment and respectfully
advises that Staff that it has revised its disclosures on the cover page, and pages 10, 107, and 108 to clarify this disclosure.

U.S